© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Equity IPOs

Top Section/Ad

Top Section/Ad

Most recent

M&A in 2026: time to summon up the blood


Country’s IPO market is returning after lull caused by political instability
◆ Why Europe's corporate bond market is on a roll ◆ Reverse Yankees, hot hybrids and huge size with more to come ◆ Europe's stock exchanges' attempts to drum up more IPOs
Hope SIU could boost retail investment flows
Shares in Optasia have risen 5% after Africa's largest listing this year
More articles/Ad

More articles/Ad

More articles

  • In the second part of GlobalCapital Asia’s awards announcements, we reveal the standout deals and banks in the equity capital market.
  • Mainland-based Jacobio Pharmaceuticals has kicked off the roadshow for its Hong Kong listing. It is eyeing a valuation of up to HK$10.6bn ($1.37bn).
  • Equity capital markets bankers are looking closely at knife-edge negotiations between the UK and the European Union over a possible trade agreement. They say a lack of progress on negotiations will likely stall dealmaking this week but a No Deal end to the transition period this year could also make deals more difficult from January.
  • Chinese financial technology company Bairong is targeting Hong Kong for its IPO, having filed a draft prospectus with the city’s bourse.
  • Three of France’s most famous entrepreneurs won acclaim from investors on Monday as they closed books on the IPO of 2MX Organic, a new €300m special purpose acquisition vehicle (Spac) that is seeking to shake up the European organic food sector.
  • In an extraordinary year for equity capital markets, the rising popularity of renewable energy stocks has been a prevailing theme and this momentum is continuing into year-end.